Kirill A. Arsentiev
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Kirill A. Arsentiev has a total of 31 co-authors. Here are the top co-authors by number of shared publications:
- Pavel E. Musienko
Scientific Center for Genetics and Life Sciences, Sirius University of Science and Technology, 1, Olympic Ave., 354340 Sochi, Russia
4 shared publications - Arseniy E. Yuzhalin
Sirius University of Science and Technologies
3 shared publications S. P. Konovalova
Department of Neurobiology, Center for Genetics and Life Sciences, Sirius University of Science and Technology, Sochi, Russia
3 shared publications- Valeriia S. Shtol
Scientific Center for Genetics and Life Sciences, Sirius University of Science and Technology, 1, Olympic Ave., 354340 Sochi, Russia
3 shared publications - Sophia Konovalova
Scientific Center for Genetics and Life Sciences, Sirius University of Science and Technology, 1, Olympic Ave., 354340 Sochi, Russia
2 shared publications А. Е. Южалин
АНОО ВО «Научно-технологический университет “Сириус”
2 shared publications
Latest Publications
- Open Access
- 29 October 2026
- Published by SPb RAACI in Medical Immunology (Russia)
- Vol. 28 (3) , 541-552
Influence of STAT1 phosphorylation at Ser727 position on CD8+T cell infiltration in central nervous system malignancies
Phosphorylation of the STAT1 protein at serine 727 position (pSTAT1_S727) is a key posttranslational modification. Its function in the anti-tumor immune response within malignant central nervous system (CNS) tumors remains poorly understood. This study aimed to determine the role of pSTAT1_S727 for anticancer immune modulation in glioblastoma, the most aggressive brain tumor. Our results have shown that STAT1_S727 phosphorylation is closely associated with activation of the anti-tumor immune system. A positive correlation was found between pSTAT1_S727 levels and expression of genes encoding components of the major histocompatibility complex class I ( MHC-I ), as well as other genes involved in tumor antigen presentation. This finding indicates that pSTAT1_S727 plays an important role in enhancing the antigen-presenting capacity of glioblastoma cells, a critical step for tumor recognition by the immune system. Furthermore, high levels of pSTAT1_S727 did significantly correlate with increased intensity of tumor infiltration by cytotoxic CD8 + T cells. These observations were consistently confirmed both by the results from glioblastoma patients, and in experimental murine models, tgus underscoring the significance of this relationship. Hence, the STAT1_ S727 phosphorylation has been considered an important molecular factor promoting the initiation of immune recognition of glioblastoma by enhancing antigen presentation and recruiting effector T cells. However, despite this pro-inflammatory role, the clinical follow-up of patients did not reveal an association between high pSTAT1_S727 levels and improved overall survival. This lack of clinical benefit may be explained by the highly immunosuppressive microenvironment of glioblastoma, with functional exhaustion of infiltrating T cells, thus facilitating the tumor evasion effects. Therefore, activation of the pSTAT1_S727 signaling pathway is necessary for initiating an immune response. However, its action is insufficient to overcome immunosuppression and achieve a significant therapeutic effect. The obtained data highlight the need for combined strategies that enhance the initiation of immune response (e.g., through STAT1 activation), along with blocking the mechanisms of T cell exhaustion within the tumor microenvironment.
- 29 October 2026
- Published by SPb RAACI in Medical Immunology (Russia)
- Vol. 28 (3) , 541-552
Open AccessInfluence of STAT1 phosphorylation at Ser727 position on CD8+T cell infiltration in central nervous system malignancies
Phosphorylation of the STAT1 protein at serine 727 position (pSTAT1_S727) is a key posttranslational modification. Its function in the anti-tumor immune response within malignant central nervous system (CNS) tumors remains poorly understood. This study aimed to determine the role of pSTAT1_S727 for anticancer immune modulation in glioblastoma, the most aggressive brain tumor. Our results have shown that STAT1_S727 phosphorylation is closely associated with activation of the anti-tumor immune system. A positive correlation was found between pSTAT1_S727 levels and expression of genes encoding components of the major histocompatibility complex class I ( MHC-I ), as well as other genes involved in tumor antigen presentation. This finding indicates that pSTAT1_S727 plays an important role in enhancing the antigen-presenting capacity of glioblastoma cells, a critical step for tumor recognition by the immune system. Furthermore, high levels of pSTAT1_S727 did significantly correlate with increased intensity of tumor infiltration by cytotoxic CD8 + T cells. These observations were consistently confirmed both by the results from glioblastoma patients, and in experimental murine models, tgus underscoring the significance of this relationship. Hence, the STAT1_ S727 phosphorylation has been considered an important molecular factor promoting the initiation of immune recognition of glioblastoma by enhancing antigen presentation and recruiting effector T cells. However, despite this pro-inflammatory role, the clinical follow-up of patients did not reveal an association between high pSTAT1_S727 levels and improved overall survival. This lack of clinical benefit may be explained by the highly immunosuppressive microenvironment of glioblastoma, with functional exhaustion of infiltrating T cells, thus facilitating the tumor evasion effects. Therefore, activation of the pSTAT1_S727 signaling pathway is necessary for initiating an immune response. However, its action is insufficient to overcome immunosuppression and achieve a significant therapeutic effect. The obtained data highlight the need for combined strategies that enhance the initiation of immune response (e.g., through STAT1 activation), along with blocking the mechanisms of T cell exhaustion within the tumor microenvironment.
- Open Access
- 29 October 2026
- Published by SPb RAACI in Medical Immunology (Russia)
- Vol. 28 (3) , 509-520
Effect of CDK5 knockdown on the cytotoxic potential of T cell subpopulations
Malignant tumors of the central nervous system (CNS) are poorly immunogenic, thus limiting the effectiveness of therapies and contributes to a dismal prognosis for patients with these malignancies. Therefore, the development of new approaches to treatment of these diseases is becoming increasingly important. Atypical cyclin-dependent kinase 5 ( CDK5 ) is involved in tumor progression and metastasis, as well as in developing immune escape by modifying the expression of MHC-I molecules and immune checkpoints, being an important candidate for regulating the molecular mechanisms of tumor growth. However, the influence of CDK5 on the functional state of T cell subsets and expression of key cytotoxic effectors in the microenvironment of primary and metastatic CNS cancers remains poorly understood. The aim of this study was to evaluate the effect of Cdk5 gene knockdown in tumor cells of murine model upon functional status of cytotoxic T lymphocytes in the microenvironment of CNS cancers in order to compare the experimental results with clinical data of patients with CNS tumors. The objectives of our study were as follows: to analyze the expression profile of genes associated with the T cell response using scRNA-seq in a murine model of the disease with CDK5 knockdown; to validate changes in infiltration and effector molecule expression using immunohistochemistry (IHC) technique; bioinformatic evaluation of correlations between CDK5 expression levels and cytotoxic genes in cohorts of patients with brain metastases and primary glioblastoma using bulk- and scRNA-seq; to assess the impact of effector molecule expression on overall patient survival. Our results indicate that CDK5 expression levels influence the transcriptional activity of genes encoding key T cell effector molecules such as perforin or granzymes. The results of this analysis may provide a more accurate prognosis of patient survival based on the level of expression of CDK5 and effector molecules. Further studies are required to elucidate the conditions and characteristics that mediate the immunomodulatory effect of CDK5 .
- 29 October 2026
- Published by SPb RAACI in Medical Immunology (Russia)
- Vol. 28 (3) , 509-520
Open AccessEffect of CDK5 knockdown on the cytotoxic potential of T cell subpopulations
Malignant tumors of the central nervous system (CNS) are poorly immunogenic, thus limiting the effectiveness of therapies and contributes to a dismal prognosis for patients with these malignancies. Therefore, the development of new approaches to treatment of these diseases is becoming increasingly important. Atypical cyclin-dependent kinase 5 ( CDK5 ) is involved in tumor progression and metastasis, as well as in developing immune escape by modifying the expression of MHC-I molecules and immune checkpoints, being an important candidate for regulating the molecular mechanisms of tumor growth. However, the influence of CDK5 on the functional state of T cell subsets and expression of key cytotoxic effectors in the microenvironment of primary and metastatic CNS cancers remains poorly understood. The aim of this study was to evaluate the effect of Cdk5 gene knockdown in tumor cells of murine model upon functional status of cytotoxic T lymphocytes in the microenvironment of CNS cancers in order to compare the experimental results with clinical data of patients with CNS tumors. The objectives of our study were as follows: to analyze the expression profile of genes associated with the T cell response using scRNA-seq in a murine model of the disease with CDK5 knockdown; to validate changes in infiltration and effector molecule expression using immunohistochemistry (IHC) technique; bioinformatic evaluation of correlations between CDK5 expression levels and cytotoxic genes in cohorts of patients with brain metastases and primary glioblastoma using bulk- and scRNA-seq; to assess the impact of effector molecule expression on overall patient survival. Our results indicate that CDK5 expression levels influence the transcriptional activity of genes encoding key T cell effector molecules such as perforin or granzymes. The results of this analysis may provide a more accurate prognosis of patient survival based on the level of expression of CDK5 and effector molecules. Further studies are required to elucidate the conditions and characteristics that mediate the immunomodulatory effect of CDK5 .
- Open Access
- 1 April 2026
- Published by Frontiers Media SA in Frontiers in Oncology
- Vol. 16, 1771697
EMILIN-1 in the tumor microenvironment: insights from CNS tumors and beyond
Elastin Microfibril Interface Located Protein 1 (EMILIN-1) is a multifunctional extracellular glycoprotein, primarily involved in maintaining tissue homeostasis. Known for regulation of elastogenesis and vascular stability, EMILIN-1 has emerged as a key modulator of multiple biological processes, including cell adhesion, migration, and proliferation. Recent experimental data highlight the importance of EMILIN-1 in cancer biology, especially in malignant tumors of the nervous system, where EMILIN-1’s regulatory functions influence tumor progression and metastatic potential. Specifically, EMILIN-1 can exert tumor-suppressive effects by modulating cell signaling pathways of tumor cells and EMILIN-1 can also alter the immune response and promote progression of brain tumors. This review article provides a comprehensive analysis of the recently discovered mechanisms through which EMILIN-1 promotes tumor progression in the nervous system and other sites.
- 1 April 2026
- Published by Frontiers Media SA in Frontiers in Oncology
- Vol. 16, 1771697
Open AccessEMILIN-1 in the tumor microenvironment: insights from CNS tumors and beyond
Elastin Microfibril Interface Located Protein 1 (EMILIN-1) is a multifunctional extracellular glycoprotein, primarily involved in maintaining tissue homeostasis. Known for regulation of elastogenesis and vascular stability, EMILIN-1 has emerged as a key modulator of multiple biological processes, including cell adhesion, migration, and proliferation. Recent experimental data highlight the importance of EMILIN-1 in cancer biology, especially in malignant tumors of the nervous system, where EMILIN-1’s regulatory functions influence tumor progression and metastatic potential. Specifically, EMILIN-1 can exert tumor-suppressive effects by modulating cell signaling pathways of tumor cells and EMILIN-1 can also alter the immune response and promote progression of brain tumors. This review article provides a comprehensive analysis of the recently discovered mechanisms through which EMILIN-1 promotes tumor progression in the nervous system and other sites.
- Open Access
Polylactide/Polycaprolactone Nanofiber Scaffold Enhances Primary Cortical Neuron Growth
Spinal cord injury (SCI) remains a major clinical challenge due to the limited regenerative capacity of the central nervous system (CNS). Effective scaffolds for repair must combine mechanical compatibility with host tissue, controlled degradation matching the time course of regeneration, and microarchitectural features that promote neuronal survival. Electrospun nanofibrous scaffolds mimic the structural and mechanical features of the extracellular matrix, providing critical cues for neuronal adhesion and glial modulation in neural regeneration. Here, we fabricated biodegradable poly(lactic acid)/poly(ε-caprolactone) (PLA/PCL) scaffolds using a dichloromethane/tetrahydrofuran (DCM/THF) solvent system to induce surface porosity via solvent-driven phase separation. The DCM/THF solvent system formulation produced nanofibers with porous surfaces and increased area for cell interaction. PLA/PCL scaffolds showed a Young’s modulus of ~26 MPa and sustained degradation, particularly under oxidative conditions simulating the post-injury microenvironment. In vitro, these scaffolds enhanced neuronal density up to fivefold and maintained ~80% viability over 10 days in primary neuron–glia cultures. Morphometric analysis revealed that DCM/THF-based scaffolds supported astrocytes with preserved process complexity and reduced circularity, indicative of a less reactive morphology. In contrast, scaffolds fabricated with 1,1,1,3,3,3-hexafluoro-2-propanol (HFIP) displayed reduced bioactivity and promoted morphological features associated with astrocyte reactivity, including cell rounding and process retraction. These findings demonstrate that solvent-driven control of scaffold microarchitecture is a powerful strategy to enhance neuronal integration and modulate glial morphology, positioning DCM/THF-processed PLA/PCL scaffolds as a promising platform for CNS tissue engineering.
Open AccessPolylactide/Polycaprolactone Nanofiber Scaffold Enhances Primary Cortical Neuron Growth
Spinal cord injury (SCI) remains a major clinical challenge due to the limited regenerative capacity of the central nervous system (CNS). Effective scaffolds for repair must combine mechanical compatibility with host tissue, controlled degradation matching the time course of regeneration, and microarchitectural features that promote neuronal survival. Electrospun nanofibrous scaffolds mimic the structural and mechanical features of the extracellular matrix, providing critical cues for neuronal adhesion and glial modulation in neural regeneration. Here, we fabricated biodegradable poly(lactic acid)/poly(ε-caprolactone) (PLA/PCL) scaffolds using a dichloromethane/tetrahydrofuran (DCM/THF) solvent system to induce surface porosity via solvent-driven phase separation. The DCM/THF solvent system formulation produced nanofibers with porous surfaces and increased area for cell interaction. PLA/PCL scaffolds showed a Young’s modulus of ~26 MPa and sustained degradation, particularly under oxidative conditions simulating the post-injury microenvironment. In vitro, these scaffolds enhanced neuronal density up to fivefold and maintained ~80% viability over 10 days in primary neuron–glia cultures. Morphometric analysis revealed that DCM/THF-based scaffolds supported astrocytes with preserved process complexity and reduced circularity, indicative of a less reactive morphology. In contrast, scaffolds fabricated with 1,1,1,3,3,3-hexafluoro-2-propanol (HFIP) displayed reduced bioactivity and promoted morphological features associated with astrocyte reactivity, including cell rounding and process retraction. These findings demonstrate that solvent-driven control of scaffold microarchitecture is a powerful strategy to enhance neuronal integration and modulate glial morphology, positioning DCM/THF-processed PLA/PCL scaffolds as a promising platform for CNS tissue engineering.
- 19 August 2025
- Published by Pleiades Publishing Ltd in Cell and Tissue Biology
- Vol. 19 (S1) , S127-S137
Neuroplastic and Neuroinflammatory Alterations in the Hippocampus after Spinal Cord Injury
Objective: Spinal cord injury (SCI) is a debilitating condition that not only affects motor and sensory functions, but also causes widespread neuroplastic and neuroinflammatory changes in the hippocampus, a brain region critical for learning and memory. Methods: This study examined region-specific changes in hippocampal subregions (CA1, CA3, and dentate gyrus) in a rat model of SCI, evaluating neurogenesis, microglial and astroglial cell activation, and behavioral outcomes. Results and Discussion: The study revealed distinct patterns of neuroplastic and neuroinflammatory changes in hippocampal subregions, with some areas showing increased susceptibility to injury-induced changes. Behavioral analyses showed a significant correlation between these hippocampal changes and impairments in memory and learning ability, highlighting the functional consequences of SCI on cognitive processes. Conclusions: The findings emphasize the importance of understanding the relationship between neuroplasticity and neuroinflammation in the hippocampus after SCI, which may facilitate the development of targeted therapeutic strategies to mitigate cognitive deficits.
- 19 August 2025
- Published by Pleiades Publishing Ltd in Cell and Tissue Biology
- Vol. 19 (S1) , S127-S137
Neuroplastic and Neuroinflammatory Alterations in the Hippocampus after Spinal Cord Injury
Objective: Spinal cord injury (SCI) is a debilitating condition that not only affects motor and sensory functions, but also causes widespread neuroplastic and neuroinflammatory changes in the hippocampus, a brain region critical for learning and memory. Methods: This study examined region-specific changes in hippocampal subregions (CA1, CA3, and dentate gyrus) in a rat model of SCI, evaluating neurogenesis, microglial and astroglial cell activation, and behavioral outcomes. Results and Discussion: The study revealed distinct patterns of neuroplastic and neuroinflammatory changes in hippocampal subregions, with some areas showing increased susceptibility to injury-induced changes. Behavioral analyses showed a significant correlation between these hippocampal changes and impairments in memory and learning ability, highlighting the functional consequences of SCI on cognitive processes. Conclusions: The findings emphasize the importance of understanding the relationship between neuroplasticity and neuroinflammation in the hippocampus after SCI, which may facilitate the development of targeted therapeutic strategies to mitigate cognitive deficits.
- 1 July 2025
- Published by Pleiades Publishing Ltd in Journal of Evolutionary Biochemistry and Physiology
- Vol. 61 (4) , 1076-1101
Neural Interfaces: Applications, Innovative Approaches, Biocompatibility, Biomimetics
The article provides a summary and critical analysis of literature data, primarily from the last five years, on neural interfaces. It overviews experimental findings and clinical outcomes from applying neural interfaces for the enhancement of human capabilities in interacting with the environment. It also illustrates how employing the latest advancements in electronics, nanoscale bioengineering, and artificial intelligence improves quality of life or can be utilized for the purposes of regenerative medicine. The review highlights the most promising types of neural interfaces, with a particular emphasis on invasive technologies and the use of cutting-edge developments in implantable materials with high biocompatibility, durability, and optimized biophysical properties. Materials for invasive technologies are evaluated in the light of their applicability for specific biomedical purposes, accompanied by a comparative analysis. Significant attention is paid to the latest technologies in the fields of biomimetics and electrical biostimulation, as well as innovative approaches to the applied aspects of brain and spinal interfaces. Thus, this review serves as a valuable source of information for students and professionals whose educational and professional interests are aimed at diving deeper into the world of neural interfaces.
- 1 July 2025
- Published by Pleiades Publishing Ltd in Journal of Evolutionary Biochemistry and Physiology
- Vol. 61 (4) , 1076-1101
Neural Interfaces: Applications, Innovative Approaches, Biocompatibility, Biomimetics
The article provides a summary and critical analysis of literature data, primarily from the last five years, on neural interfaces. It overviews experimental findings and clinical outcomes from applying neural interfaces for the enhancement of human capabilities in interacting with the environment. It also illustrates how employing the latest advancements in electronics, nanoscale bioengineering, and artificial intelligence improves quality of life or can be utilized for the purposes of regenerative medicine. The review highlights the most promising types of neural interfaces, with a particular emphasis on invasive technologies and the use of cutting-edge developments in implantable materials with high biocompatibility, durability, and optimized biophysical properties. Materials for invasive technologies are evaluated in the light of their applicability for specific biomedical purposes, accompanied by a comparative analysis. Significant attention is paid to the latest technologies in the fields of biomimetics and electrical biostimulation, as well as innovative approaches to the applied aspects of brain and spinal interfaces. Thus, this review serves as a valuable source of information for students and professionals whose educational and professional interests are aimed at diving deeper into the world of neural interfaces.
- 1 December 2024
- Published by Pleiades Publishing Ltd in Journal of Evolutionary Biochemistry and Physiology
- Vol. 60 (S1) , S23-S49
Cell Therapy and Biomaterials: Modern Approaches in the Treatment of Spinal Cord Injury
Spinal cord injury (SCI) is a complex pathology with a multifaceted pathogenesis and, to date, no definitive treatment strategy. Among emerging therapeutic approaches, a combination strategy leveraging biomaterial-based scaffolds for the delivery of both cells and therapeutic agents to the injured spinal cord has shown significant promise. While standalone cell therapies often demonstrate limited efficacy, biomaterial scaffolds can protect transplanted cells from the hostile microenvironment of the injury site and provide a supportive matrix for cell adhesion and subsequent integration into the host neural tissue. Contemporary approaches in cell and organoid therapy, combined with smart biomaterials that can dynamically adapt their properties in response to specific stimuli, present unprecedented opportunities for SCI treatment. This review aims to provide a comprehensive overview of the recent advances in SCI therapies involving cell transplantation and biomaterial scaffolds, with a particular focus on their combinations. It highlights the strengths and limitations of different types of cell transplantation, including less conventional approaches, discusses brain organoid transplantation methods, and identifies the most frequently used scaffold types selected based on their mechanical properties and 3D architecture.
- 1 December 2024
- Published by Pleiades Publishing Ltd in Journal of Evolutionary Biochemistry and Physiology
- Vol. 60 (S1) , S23-S49
Cell Therapy and Biomaterials: Modern Approaches in the Treatment of Spinal Cord Injury
Spinal cord injury (SCI) is a complex pathology with a multifaceted pathogenesis and, to date, no definitive treatment strategy. Among emerging therapeutic approaches, a combination strategy leveraging biomaterial-based scaffolds for the delivery of both cells and therapeutic agents to the injured spinal cord has shown significant promise. While standalone cell therapies often demonstrate limited efficacy, biomaterial scaffolds can protect transplanted cells from the hostile microenvironment of the injury site and provide a supportive matrix for cell adhesion and subsequent integration into the host neural tissue. Contemporary approaches in cell and organoid therapy, combined with smart biomaterials that can dynamically adapt their properties in response to specific stimuli, present unprecedented opportunities for SCI treatment. This review aims to provide a comprehensive overview of the recent advances in SCI therapies involving cell transplantation and biomaterial scaffolds, with a particular focus on their combinations. It highlights the strengths and limitations of different types of cell transplantation, including less conventional approaches, discusses brain organoid transplantation methods, and identifies the most frequently used scaffold types selected based on their mechanical properties and 3D architecture.
- 1 September 2024
- Published by Pleiades Publishing Ltd in Journal of Evolutionary Biochemistry and Physiology
- Vol. 60 (5) , 1943-1959
Role of the Serotonergic System in Functional Recovery after Spinal Cord Injury
The serotonergic system plays an essential role in the modulation of the spinal network activity involved in the control of motor, sensory, and visceral functions. Spinal cord injury (SCI) can induce a state of overexcitation that contributes to pain, spasticity, and autonomic dysfunction. At the same time, serotonergic axons are known to adapt to pathophysiological changes faster than the other axons and retain the ability to sprout and regenerate after injury. A number of experimental animal studies, as well as some clinical observations, suggest that the serotonergic system is a key endogenous resource for posttraumatic recovery after SCI. Specific therapy may include the administration of serotonergic drugs and intraspinal transplantation of serotonergic neurons. This review addresses the role of the serotonergic system in functional recovery after SCI and the prospects for the use of serotonergic drugs in neurorehabilitation.
- 1 September 2024
- Published by Pleiades Publishing Ltd in Journal of Evolutionary Biochemistry and Physiology
- Vol. 60 (5) , 1943-1959
Role of the Serotonergic System in Functional Recovery after Spinal Cord Injury
The serotonergic system plays an essential role in the modulation of the spinal network activity involved in the control of motor, sensory, and visceral functions. Spinal cord injury (SCI) can induce a state of overexcitation that contributes to pain, spasticity, and autonomic dysfunction. At the same time, serotonergic axons are known to adapt to pathophysiological changes faster than the other axons and retain the ability to sprout and regenerate after injury. A number of experimental animal studies, as well as some clinical observations, suggest that the serotonergic system is a key endogenous resource for posttraumatic recovery after SCI. Specific therapy may include the administration of serotonergic drugs and intraspinal transplantation of serotonergic neurons. This review addresses the role of the serotonergic system in functional recovery after SCI and the prospects for the use of serotonergic drugs in neurorehabilitation.